Literature DB >> 18636153

The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells.

Patrizia Portanova1, Tiziana Russo, Ornella Pellerito, Giuseppe Calvaruso, Michela Giuliano, Renza Vento, Giovanni Tesoriere.   

Abstract

Histone deacetylase inhibitors (HDACIs) activate genes that promote cell cycle arrest and apoptosis in a number of tumor cells. This study showed that suberoylanilide hydroxamic acid (SAHA), a potent and commonly used HDACI, induced apoptosis in human colon adenocarcinoma HT-29 cells in a time- and dose-dependent manner. This effect was accompanied by the induction of oxidative stress, dissipation of mitochondrial transmembrane potential and activation of executioner caspases. Moreover, SAHA increased the levels of phosphorylated active forms of p38 and JNK. The addition of either the antioxidant N-acetylcysteine or the specific inhibitor of NADPH oxidase diphenylene iodonium chloride reduced the cytotoxic effects of SAHA in HT-29 cells, suggesting that the induction of oxidative stress represents a crucial event in the apoptotic mechanism. In addition, SAHA up-regulated the death receptor DR5, inducing the activation of caspase-8 with the consequent cleavage of Bid. Furthermore, SAHA down-regulated FLIPL and Akt, two proteins which exert an inhibitory role in apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636153

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Andrew Advani; Qingling Huang; Kerri Thai; Suzanne L Advani; Kathryn E White; Darren J Kelly; Darren A Yuen; Kim A Connelly; Philip A Marsden; Richard E Gilbert
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer.

Authors:  Peter M Wilson; Melissa J Labonte; Shelby C Martin; Stephanie T Kuwahara; Anthony El-Khoueiry; Heinz-Josef Lenz; Robert D Ladner
Journal:  Invest New Drugs       Date:  2013-01-09       Impact factor: 3.850

3.  Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms.

Authors:  Teneille Walker; Clint Mitchell; Margaret A Park; Adly Yacoub; Martin Graf; Mohamed Rahmani; Peter J Houghton; Christina Voelkel-Johnson; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

4.  The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.

Authors:  Antonella Di Costanzo; Nunzio Del Gaudio; Lidio Conte; Carmela Dell'Aversana; Michiel Vermeulen; Hugues de Thé; Antimo Migliaccio; Angela Nebbioso; Lucia Altucci
Journal:  Oncogene       Date:  2018-02-22       Impact factor: 9.867

5.  Sicilian Litchi Fruit Extracts Induce Autophagy versus Apoptosis Switch in Human Colon Cancer Cells.

Authors:  Sonia Emanuele; Antonietta Notaro; Antonio Palumbo Piccionello; Antonella Maggio; Marianna Lauricella; Antonella D'Anneo; Cesare Cernigliaro; Giuseppe Calvaruso; Michela Giuliano
Journal:  Nutrients       Date:  2018-10-12       Impact factor: 5.717

6.  DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

Authors:  Melissa J LaBonte; Peter M Wilson; William Fazzone; Susan Groshen; Heinz-Josef Lenz; Robert D Ladner
Journal:  BMC Med Genomics       Date:  2009-11-30       Impact factor: 3.063

Review 7.  Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.

Authors:  Matthew W Lawless; Kenneth J O'Byrne; Steven G Gray
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

8.  Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulation.

Authors:  Laura Bergadà; Andree Yeramian; Annabel Sorolla; Xavier Matias-Guiu; Xavier Dolcet
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.